Loading clinical trials...
Loading clinical trials...
The goal of this clinical trial is to evaluate the safety and immune responses of three different dose levels a self-amplifying RNA pandemic influenza vaccine (ARCT-2304) in adults. The key objectives...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Arcturus Therapeutics, Inc.
Collaborators
NCT05648448 · Influenza, Influenza, Human
NCT06355232 · covid19 Infection, Influenza, Human
NCT04494412 · Influenza, Human, Arthralgia
NCT07204964 · Influenza, Human
NCT05110911 · Influenza, Human, SARS-CoV-2 Infection
Velocity Clinical Research
La Mesa, California
Velocity Clinical Research
San Bernardino, California
Tekton Research
Longmont, Colorado
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions